Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis

Context: The lack of sensitivity and specificity of the existing diagnostic markers in Rheumatoid arthritis (RA) stimulates the search for new biomarkers to improve diagnostic sensitivity especially in seronegative cases. Aims: To estimate the levels of 14-3-3 η in RA cases, to assess the positivity...

Full description

Saved in:
Bibliographic Details
Main Authors: Lakshmi Deepika Yarlagadda, Rachel Jacob, D Liza Rajasekhar, Krishna Mohan Iyyapu, Sai Baba S S. Kompella, Vijaya Bhaskar Madrol, N N Sreedevi, Siraj Ahmed Khan, Noorjahan Mohammed
Format: Article
Language:English
Published: SAGE Publishing 2020-01-01
Series:Indian Journal of Rheumatology
Subjects:
Online Access:http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=3;spage=175;epage=180;aulast=Yarlagadda
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544225706639360
author Lakshmi Deepika Yarlagadda
Rachel Jacob
D Liza Rajasekhar
Krishna Mohan Iyyapu
Sai Baba S S. Kompella
Vijaya Bhaskar Madrol
N N Sreedevi
Siraj Ahmed Khan
Noorjahan Mohammed
author_facet Lakshmi Deepika Yarlagadda
Rachel Jacob
D Liza Rajasekhar
Krishna Mohan Iyyapu
Sai Baba S S. Kompella
Vijaya Bhaskar Madrol
N N Sreedevi
Siraj Ahmed Khan
Noorjahan Mohammed
author_sort Lakshmi Deepika Yarlagadda
collection DOAJ
description Context: The lack of sensitivity and specificity of the existing diagnostic markers in Rheumatoid arthritis (RA) stimulates the search for new biomarkers to improve diagnostic sensitivity especially in seronegative cases. Aims: To estimate the levels of 14-3-3 η in RA cases, to assess the positivity of 14-3-3 η in seronegative RA and to correlate rheumatoid factor (RF) positivity with 14-3-3 η positivity in seropositive RA. Settings and Design: This was cross sectional case control study by the Departments of Biochemistry and Rheumatology and clinical immunology. Subjects and Methods: A total of 61 RA cases and 20 healthy controls were included. Erythrocyte sedimentation rate, high sensitivity C reactive protein, RF, anti-citrullinated peptide antibodies (CCP) and 14-3-3 η protein were estimated. RA cases were further classified as seropositive (n = 23) and seronegative (n = 38) based on the positivity of either RF or anti-CCP result. Statistical Analysis: Prism 7 (GraphPad Software Inc.). Results: The median levels of 14-3-3 η (ng/ml) in cases (0.66 [0.2–1.1]) were significantly high compared to controls (0.1 [0.07–0.28]), P < 0.0001. It had a sensitivity of 74% and specificity of 90% at >0.3 ng/ml. 14-3-3 η showed statistically significant difference between seronegative cases and controls (P = 0.0003). The sensitivity and specificity of RF and anti-CCP were 33% and 85% and 37% and 90% respectively. The combination of 14-3-3 η, RF and anti-CCP showed sensitivity and specificity of 85.4% and 100% respectively with area under the curve 0.927. Conclusions: Our study demonstrated that serum levels of 14-3-3 η were significantly higher in cases compared to controls. Seronegative RA cases showed 14-3-3 η positivity in 71% of cases. 14-3-3 η appears to be a useful and highly specific marker in RA.
format Article
id doaj-art-c8ec00ab1d4047629f7e69e90617d5dc
institution Kabale University
issn 0973-3698
0973-3701
language English
publishDate 2020-01-01
publisher SAGE Publishing
record_format Article
series Indian Journal of Rheumatology
spelling doaj-art-c8ec00ab1d4047629f7e69e90617d5dc2025-02-03T10:51:12ZengSAGE PublishingIndian Journal of Rheumatology0973-36980973-37012020-01-0115317518010.4103/injr.injr_30_20Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritisLakshmi Deepika YarlagaddaRachel JacobD Liza RajasekharKrishna Mohan IyyapuSai Baba S S. KompellaVijaya Bhaskar MadrolN N SreedeviSiraj Ahmed KhanNoorjahan MohammedContext: The lack of sensitivity and specificity of the existing diagnostic markers in Rheumatoid arthritis (RA) stimulates the search for new biomarkers to improve diagnostic sensitivity especially in seronegative cases. Aims: To estimate the levels of 14-3-3 η in RA cases, to assess the positivity of 14-3-3 η in seronegative RA and to correlate rheumatoid factor (RF) positivity with 14-3-3 η positivity in seropositive RA. Settings and Design: This was cross sectional case control study by the Departments of Biochemistry and Rheumatology and clinical immunology. Subjects and Methods: A total of 61 RA cases and 20 healthy controls were included. Erythrocyte sedimentation rate, high sensitivity C reactive protein, RF, anti-citrullinated peptide antibodies (CCP) and 14-3-3 η protein were estimated. RA cases were further classified as seropositive (n = 23) and seronegative (n = 38) based on the positivity of either RF or anti-CCP result. Statistical Analysis: Prism 7 (GraphPad Software Inc.). Results: The median levels of 14-3-3 η (ng/ml) in cases (0.66 [0.2–1.1]) were significantly high compared to controls (0.1 [0.07–0.28]), P < 0.0001. It had a sensitivity of 74% and specificity of 90% at >0.3 ng/ml. 14-3-3 η showed statistically significant difference between seronegative cases and controls (P = 0.0003). The sensitivity and specificity of RF and anti-CCP were 33% and 85% and 37% and 90% respectively. The combination of 14-3-3 η, RF and anti-CCP showed sensitivity and specificity of 85.4% and 100% respectively with area under the curve 0.927. Conclusions: Our study demonstrated that serum levels of 14-3-3 η were significantly higher in cases compared to controls. Seronegative RA cases showed 14-3-3 η positivity in 71% of cases. 14-3-3 η appears to be a useful and highly specific marker in RA.http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=3;spage=175;epage=180;aulast=Yarlagaddaanti-citrullinated peptide antibodiesrheumatoid factorseronegative and seropositive
spellingShingle Lakshmi Deepika Yarlagadda
Rachel Jacob
D Liza Rajasekhar
Krishna Mohan Iyyapu
Sai Baba S S. Kompella
Vijaya Bhaskar Madrol
N N Sreedevi
Siraj Ahmed Khan
Noorjahan Mohammed
Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
Indian Journal of Rheumatology
anti-citrullinated peptide antibodies
rheumatoid factor
seronegative and seropositive
title Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
title_full Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
title_fullStr Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
title_full_unstemmed Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
title_short Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
title_sort evaluation of a new biomarker 14 3 3 eta protein in diagnosis of rheumatoid arthritis
topic anti-citrullinated peptide antibodies
rheumatoid factor
seronegative and seropositive
url http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2020;volume=15;issue=3;spage=175;epage=180;aulast=Yarlagadda
work_keys_str_mv AT lakshmideepikayarlagadda evaluationofanewbiomarker1433etaproteinindiagnosisofrheumatoidarthritis
AT racheljacob evaluationofanewbiomarker1433etaproteinindiagnosisofrheumatoidarthritis
AT dlizarajasekhar evaluationofanewbiomarker1433etaproteinindiagnosisofrheumatoidarthritis
AT krishnamohaniyyapu evaluationofanewbiomarker1433etaproteinindiagnosisofrheumatoidarthritis
AT saibabasskompella evaluationofanewbiomarker1433etaproteinindiagnosisofrheumatoidarthritis
AT vijayabhaskarmadrol evaluationofanewbiomarker1433etaproteinindiagnosisofrheumatoidarthritis
AT nnsreedevi evaluationofanewbiomarker1433etaproteinindiagnosisofrheumatoidarthritis
AT sirajahmedkhan evaluationofanewbiomarker1433etaproteinindiagnosisofrheumatoidarthritis
AT noorjahanmohammed evaluationofanewbiomarker1433etaproteinindiagnosisofrheumatoidarthritis